Health Economics for Non-Health-Economists
By Prof. Dr. Lieven Annemans
Course Details
Course Details
Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile.
Therefore, all managers in clinical development, regulatory, market access (and related), medical affairs and marketing should understand the fundamentals of health economic evaluations and budget impact analysis.
Only then will they take product-related decisions that consider the payers’ perspectives and optimally communicate value to payers, KOLs and other external stakeholders.
Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.
By participating, you will not only have the chance to ask your specific questions to a renowned expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.
The logic and math behind QALYs, ICERs, decision-trees and Markov models.
How external stakeholders use and challenge health economic evidence.
To distinguish good from bad health economic evaluation studies (of your brand or its competitors).
Key principles of cost-effectiveness analysis and Budget Impact Analysis.
The role of health economic evaluations in clinical research, pricing & reimbursement decisions, and post-launch.
To see the detailed agenda, please submit your details in the form below the table.
Day 1
| 10:00 | Welcome & General Introduction |
| 10:30 | Health Economic Evaluations: Why and How |
| 12:00 | Health Economic Modelling – Commonly Used Models |
| 13:15 | Lunch Break |
| 14:00 | Cost Analysis and Budget Impact Analysis. Key Principles |
| 15:45 | Prospective Research for Health Economic Evaluations |
| 17:00 | Close Day 1 |
Day 2
| 09:00 | Recap of Day 1 through Exercises on QALYs & ICERs |
| 09:45 | Guidelines for Health Economic Evaluations |
| 10:45 | Guidelines for Health Economic Evaluations (continued) |
| 12:30 | Lunch Break |
| 13:15 | Use of Health Economic Evaluations in Price & Reimbursement Decision Making |
| 14:30 | Health Economic Evaluations in a Pharmaceutical Drug’s Life Cycle |
| 15:00 | Break-Out Session: Developing Together a Health Economic Strategy |
| 16:00 | Final Discussion |
| 16:15 | End of Course |
To see the detailed agenda, please submit your details in the form below:
Watch Lieven explain the content of his 2-day course in the below 2-min video:
What is the difference with the Online Self-study Programme Basics of Health Economics?
The 2-day face-to-face course has more breadth and depth in both theory (lectures) and practice (group work). For instance, the 2-hour module on the “Guidelines for Health Economic Evaluations” is highly valued because of the interactive group work session on a health economic publication.
In a face-to-face classroom training, you learn a lot from your industry peers because of the exchange of experiences and ideas and the discussions about issues you face in your function. The Q&A sessions are very rich and you will have many opportunities for conversations with your peers outside the formal programme.
Participating in the 2-day course gives the opportunity to meet Prof. Dr. Lieven Annemans and discuss your own projects/issues with him during the breaks.
Prof. Dr. Lieven Annemans has participated in more than 400 health economic evaluations in over 20 countries across a wide spectrum of therapeutic areas. He has also been involved as an expert in a large number of Health Technology Assessments (HTAs) and is actively involved in HTA on a European level.
Lieven has a unique profile: academic professor, past-president of ISPOR, author of Health economics for non-economists (Pelckmans Pro, 2018), trainer and consultant.
Highly respected for his vast international and cross-therapeutic experience, Lieven is a much sought-after advisor and educator to health policy makers and the innovative healthcare industry.
Lieven has been on CELforPharma faculty since 2009 and is always applauded by participants for his engaging and fun teaching style.
As the course title suggests, this course is designed for non-health-economists.
As pharma companies are facing ever-increasing hurdles to optimise market access for their brands, all managers in product development, medical affairs and marketing should attend this course so that they can contribute to a successful integration of health economic evaluations into clinical, medical and brand plans.
While most of the examples and exercises discussed in this course are about pharmaceuticals, this course is equally relevant to, and has always been highly valued by, executives from the medical devices industry.
Would you like to receive a list of anonymised participant profiles from previous sessions?
The average Recommendation Score from participants of the last session was
9,6/10!
Read this selection of testimonials from recent participants:
Excellent content with enough details to provide the basics, but not too much to get annoyed if not in the field. The trainer motivates and engages everybody in the discussion and demonstrates in-depth knowledge of the topics. Organisation was great, from planning to attendance. In summary, this was an intense 2-day intense course of great value! I recommend attending this course to achieve better team work within cross-functional teams in the pharma industry!
Viatris
Laura Colombo, Global Medical Manager - Italy - October 2023
It was an enlightening experience. The brilliance in delivery by the seasoned health economics professor made complex topics easily digestible and engaging. The depth of each subject was precisely calibrated to our backgrounds, ensuring we left with both a comprehensive understanding and a sparked curiosity. For anyone seeking a solid foundation in health economics without being overwhelmed, this course is a beacon of excellence. Highly recommended!
ADVANZ Pharma
Dragos Mosneagu, Senior Manager in Portfolio Strategy - United Kingdom - October 2023
Couldn't recommend highly enough!
Pfizer
Margaret McDonnell, Market Access Director - Ireland - October 2023
Excellent course. Lieven Annemans made complicated models easy to understand.
Takeda
Birgitte Stroyer, Market Access Lead - Denmark - March 2023
My objective is fully met, namely to understand the basics, being able to calculate, understand and practice calculations (ICER, decision tree, etc). This allows me to become a better sparring partner internally and externally on HE - related topics and discussions.
Boehringer Ingelheim
Joey Dirker, Head of Go-To-Market Transformation Office - Germany - March 2023
Well-recommended courses. You can't find any better courses throughout the world.
MSD
Khaled Arman, Oncology Market Access Manager Jordan & Iran - Jordan - March 2023
Brilliant course design and content. Very relevant, I finished the course feeling like a HE specialist.
UCB
Sam Aldamee, Market Access Lead - United Kingdom - March 2023
A very concrete training with practical cases. Suitable for refreshing your knowledge or getting more insights.
Acticor
Adeline Meilhoc, Head of Global Clinical Development - France - March 2023
Great course that completely met my expectations. I really appreciated the discussions with Lieven and the group, the workshops (break-out sessions) were really useful and relevant.
Ferring
Mariia Tykhonova, Global Medical Training Manager, GMA Medical Excellence - France - December 2022
This course is a concise and well-structured introduction into Health Economics. It helped me to put my initial knowledge into context. In the future I will be able to discuss with Market Access and Pricing colleagues in a more targeted and qualified way. Thanks.
CSL Behring
Gunnar Philipp, Senior Director Medical Affairs - Switzerland - December 2022
Very knowledgeable expert and great added value. Would recommend and attend other courses. Also, very friendly and helpful staff.
Idorsia Pharmaceuticals
Inês Carreira Figueiredo, Medical Doctor, Medical Advisor - United Kingdom - December 2022
Excellent course by a highly professional expert.
MSD
Sherif Alam, Regional Marketing Director - United Arab Emirates - December 2022
Everything was very clearly explained in an engaging way.
Ferring
Kathryn Charlwood, Medical Communications Manager - Ireland - December 2022
Well organised, interactive, clear and meeting expectations: I recommend!
CSL Behring
Sandra Le Quellec, Director Medical Affairs Europe Gene Therapy/Hematology - France - December 2022
The programme is very well balanced in terms of topics, theory and examples and organisation of the course. The lecturer is brilliant. Thanks!
Novartis
Mariya Vladova, Innovative Market Access, Value and Data Insights Manager - Bulgaria - June 2022
Very comprehensive, yet practical and quick, introductory course into HEOR. Lieven is a knowledgeable, clear talker, enthusiastic about his field. Mixed audience in level of experience and companies, very nice. Thanks for everything, I enjoyed the training - it was very useful, nice and well organised.
Astellas
Olga Wedemeier, Sr. Medical Director BeNeLux - The Netherlands - June 2022
Lieven Annemans and his expertise made this a great course. I highly valued the examples from real life, the very clear theory and presentation and also the exercises. I really recommend this course.
Daiichi Sankyo
Pinar Özeken, Director Pricing & Value & Access Specialty Business Division Daiichi Sankyo Europe - Germany - June 2022
This training is a must for non-HE who want to develop further in HE.
GlaxoSmithKline
Raymond Kienhuis, Field Market Access Manager - The Netherlands - June 2022
This training is a MUST for any professional new to the pharma sector. The big picture and key principles of Health Economics are presented in a comprehensive manner and are accompanied with many actionable insights.
Janssen
Jonathan Dicker, Manager Global Pricing Analytics - Belgium - December 2021
The course was very insightful. The expert knowledge of Lieven and his great way of disseminating his knowledge made the course very valuable. Although the course was mainly discussing examples from the pharmaceutical industry, the methods and general application of HE were easily understandable and could easily be transitioned to the medical technology industry as well. Anyone can easily follow the course and really gain sufficient knowledge and insight in HE evaluations, market access methodologies that can help companies improve their chances in achieving greater market access, and efficient ways to approach information and data gathering for amplifying the value of new technologies. Highly recommended!
MedTech Europe
Panagiotis Kokkinos, Digital Health Access Officer - Belgium - December 2021
Lieven really inspired me during this 2-day course.
Janssen
Rudy Taels, Business Intelligence Manager Neurosciences Benelux - The Netherlands - December 2021
A very complete, very insightful course that is useful to apply in a company setting. For me the online experience was excellent, no improvements needed. Thanks a lot to Lieven and to CELforPharma!
Roche
Christel Van-Weert, Head of Reputation Management - Belgium - June 2021
A very clear & concise course that was perfectly fitted to my level of understanding. Not too simple, not too advanced, with a nice balance of lectures and exercises. There was some really fun and constructive interaction within the group and it was interesting to hear from other countries' perspectives during group discussions. Many thanks to all involved!
Sanofi
Erland Marstein, Franchise Lead Immunology Norway - Norway - June 2021
This was a great opportunity to brush up on some skills and to interact with a knowledge expert in the field.
Novartis
Albert Hsu, Director, Global Market Access - Switzerland - March 2021
The HE course was absolutely excellent, pitched at the right level and helped me understand (and demystify!) this topic! There is an excellent balance between theory and practices with tangible real-life examples/illustrations. The trainer was excellent, showed huge expertise and was engaging! I strongly recommend this course!
Vertex Pharmaceuticals
Celine Ladure, International Marketing Director - United Kingdom - March 2021
I highly enjoyed the course. In only 2 days you get a great overview of HE and a couple of very pragmatic tools for how to think about issues in the field, as a layman. The theory becomes very tangible and applicable in everyday life.
Pfizer
Claire-Marie Rothlübbers, Sr Manager Market Access - Switzerland - March 2021
I just loved it! Great training, great teacher, perfectly managed by CELforPharma. It was a perfect mix of theory, group exercises, individual exercises, and discussions. These two days will provide you with all the needed tools to understand and challenge health economics models.
AbbVie
Jade Royers, Jade Royers, Market Access Value Proposition Manager - Belgium - March 2021
I have left the course with a lot more understanding of health economic evaluations, and the complexity in coming up with the data to inform payers and pharma companies in making decisions regarding treatment options. I plan to also follow the HTA course to see what the difference is and explore the possibility of specialising in this field.
Novo Nordisk
Monica Mirigo, Quality Assurance Specialist for Middle Africa - Kenya - March 2021
Very rich and intense experience taking this course. Would highly recommend to anyone looking to sharpen their knowledge and Health Economics understanding and its application in Pharma.
Novo Nordisk
Peter Mburu, Medical Advisor - Southern Africa - Kenya - March 2021
14-15 December 2023, Brussels
Full Fee € 3 070
26-27 March 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 09/02/2024)
3-4 October 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 16/08/2024)
4-5 December 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 18/10/2024)
Important information:
- Our courses typically take place between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
- Live online sessions will be hosted in Zoom.
- Face-to-face courses will take place at a four-star business hotel close to the airport.
- You will receive all practical details after your registration.
For any questions related to the above, please do not hesitate to email Lisa Causero or contact her by phone at +32 484 70 91 97.
How to Register
Click the green "Register" button on the course session of your preference.
The registration wizard will guide you through the personal and company data that we need to process your registration.
You have the choice between 2 payment options:
Payment by credit card. You will not be required to pay immediately, but you will receive a secured payment link together with the invoice.
Payment via bank transfer
Click "Register Now". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.
For assistance with your registration, please email Annelies Swaan or contact her by phone at +32 486 98 52 49.
Included in the Registration Fee:
For face-to-face courses:
Participation in a small-class (max 20 participants), expert led face-to-face course with interactive group exercises and plenary discussions. You will have the opportunity to meet the expert and discuss your own projects/issues during the breaks.
Course material will be provided to you in both digital format (by email) and in hard copy (so you can make notes during the course).
Opportunities for networking and informal discussions during coffee/tea breaks and lunch.
A group dinner in a nearby restaurant on the evening of day 1.
Certificate of attendance signed by the expert and CELforPharma.
VAT Information
The prices on our website are excluding VAT. Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT.
We are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Group Discounts
Team discounts can be offered to 3 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
Transfer & Cancellation Policy
Flexible Transfer
If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
Alternatively, the registrant can transfer once on a “space available” basis at no extra cost, until 3 weeks prior to the event, to another course of the same value held within one year of the original course date.
Registration Cancellation
Less than 14 days prior to the course date: registrant liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: registrant liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: registrant liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.
Benefits of CELforPharma’s face-to-face courses:
You have the unique opportunity to interact 1:1 with the expert(s).
Plenty of opportunity for informal 1:1 and group conversations with your international peers to exchange experiences and ideas, to discuss issues and to network.
Face-to-face interactions allow for more depth during Q&As and group work.
You can step away from your daily routine in the office and enjoy a more focused learning experience in a comfortable business hotel environment.
Benefits of CELforPharma’s live online courses:
The formal programme is as impactful as a face-to-face course thanks to the highly interactive format (using breakouts, polls, quizzes …).
No travel & accommodation expenses
You can attend the course from the comfort of your own office or home.
We send you the course materials by post so that you can take notes and fully engage with the course content.
No, if you choose credit card payment, we will send you a secure payment link together with the invoice.
Team discounts can be offered for 3 or more registrations confirmed at the same time. The level of discount will depend on the number of registrations and the availability of seats.
Email Annelies Swaan, Director Business Operations, for more details.
Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Our face-to-face courses in Brussels take place in four-star business hotels close to the airport. As part of our strong relationship with these hotels, CELforPharma has secured a discount on the daily room rate for our delegates who book their accommodation via us.
Upon your registration, we will assist you to make your hotel booking. For any assistance in this matter please do not hesitate to email Lisa Causero, Programme Coordinator, or contact her by phone at +32 484 70 91 97.
We do not record our live online public courses as we want to offer a safe environment for all attendees to share their experiences and freely ask questions.
This way, by participating in our courses, you do not only learn from our expert faculty but also from your international peers in the room.
No, we don't sell the course materials as a stand-alone.
Without the expert's explanation, the exercises and the discussions with other course participants, there is very little value in the slides.
Email Inge Cornelis, partner with CELforPharma, to help you choose the course that is best suited.
Yes!
We have helped many managers with setting up an in-house training programme for their team.
Email Inge Cornelis, partner with CELforPharma, to discuss your team training needs.
Do you have any other questions?
Email Annelies Swaan or call +32 486 98 52 49.
People attending this course are typically also interested in:
By clicking the below button, you will save this course to MY COURSES in the upper right corner of the website. This allows you to quickly retrieve it later.
Don’t forget to make a personal account using the Login button in the upper right corner of the website to keep your list of saved courses for your next visit.
Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile.
Therefore, all managers in clinical development, regulatory, market access (and related), medical affairs and marketing should understand the fundamentals of health economic evaluations and budget impact analysis.
Only then will they take product-related decisions that consider the payers’ perspectives and optimally communicate value to payers, KOLs and other external stakeholders.
Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.
By participating, you will not only have the chance to ask your specific questions to a renowned expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.
The logic and math behind QALYs, ICERs, decision-trees and Markov models.
How external stakeholders use and challenge health economic evidence.
To distinguish good from bad health economic evaluation studies (of your brand or its competitors).
Key principles of cost-effectiveness analysis and Budget Impact Analysis.
The role of health economic evaluations in clinical research, pricing & reimbursement decisions, and post-launch.
To see the detailed agenda, please submit your details in the form below the table.
Day 1
| 10:00 | Welcome & General Introduction |
| 10:30 | Health Economic Evaluations: Why and How |
| 12:00 | Health Economic Modelling – Commonly Used Models |
| 13:15 | Lunch Break |
| 14:00 | Cost Analysis and Budget Impact Analysis. Key Principles |
| 15:45 | Prospective Research for Health Economic Evaluations |
| 17:00 | Close Day 1 |
Day 2
| 09:00 | Recap of Day 1 through Exercises on QALYs & ICERs |
| 09:45 | Guidelines for Health Economic Evaluations |
| 10:45 | Guidelines for Health Economic Evaluations (continued) |
| 12:30 | Lunch Break |
| 13:15 | Use of Health Economic Evaluations in Price & Reimbursement Decision Making |
| 14:30 | Health Economic Evaluations in a Pharmaceutical Drug’s Life Cycle |
| 15:00 | Break-Out Session: Developing Together a Health Economic Strategy |
| 16:00 | Final Discussion |
| 16:15 | End of Course |
To see the detailed agenda, please submit your details in the form below:
Watch Lieven explain the content of his 2-day course in the below 2-min video:
What is the difference with the Online Self-study Programme Basics of Health Economics?
The 2-day face-to-face course has more breadth and depth in both theory (lectures) and practice (group work). For instance, the 2-hour module on the “Guidelines for Health Economic Evaluations” is highly valued because of the interactive group work session on a health economic publication.
In a face-to-face classroom training, you learn a lot from your industry peers because of the exchange of experiences and ideas and the discussions about issues you face in your function. The Q&A sessions are very rich and you will have many opportunities for conversations with your peers outside the formal programme.
Participating in the 2-day course gives the opportunity to meet Prof. Dr. Lieven Annemans and discuss your own projects/issues with him during the breaks.
Prof. Dr. Lieven Annemans has participated in more than 400 health economic evaluations in over 20 countries across a wide spectrum of therapeutic areas. He has also been involved as an expert in a large number of Health Technology Assessments (HTAs) and is actively involved in HTA on a European level.
Lieven has a unique profile: academic professor, past-president of ISPOR, author of Health economics for non-economists (Pelckmans Pro, 2018), trainer and consultant.
Highly respected for his vast international and cross-therapeutic experience, Lieven is a much sought-after advisor and educator to health policy makers and the innovative healthcare industry.
Lieven has been on CELforPharma faculty since 2009 and is always applauded by participants for his engaging and fun teaching style.
As the course title suggests, this course is designed for non-health-economists.
As pharma companies are facing ever-increasing hurdles to optimise market access for their brands, all managers in product development, medical affairs and marketing should attend this course so that they can contribute to a successful integration of health economic evaluations into clinical, medical and brand plans.
While most of the examples and exercises discussed in this course are about pharmaceuticals, this course is equally relevant to, and has always been highly valued by, executives from the medical devices industry.
Would you like to receive a list of anonymised participant profiles from previous sessions?
The average Recommendation Score from participants of the last session was
9,6/10!
Read this selection of testimonials from recent participants:
Excellent content with enough details to provide the basics, but not too much to get annoyed if not in the field. The trainer motivates and engages everybody in the discussion and demonstrates in-depth knowledge of the topics. Organisation was great, from planning to attendance. In summary, this was an intense 2-day intense course of great value! I recommend attending this course to achieve better team work within cross-functional teams in the pharma industry!
Viatris
Laura Colombo, Global Medical Manager - Italy - October 2023
It was an enlightening experience. The brilliance in delivery by the seasoned health economics professor made complex topics easily digestible and engaging. The depth of each subject was precisely calibrated to our backgrounds, ensuring we left with both a comprehensive understanding and a sparked curiosity. For anyone seeking a solid foundation in health economics without being overwhelmed, this course is a beacon of excellence. Highly recommended!
ADVANZ Pharma
Dragos Mosneagu, Senior Manager in Portfolio Strategy - United Kingdom - October 2023
Couldn't recommend highly enough!
Pfizer
Margaret McDonnell, Market Access Director - Ireland - October 2023
Excellent course. Lieven Annemans made complicated models easy to understand.
Takeda
Birgitte Stroyer, Market Access Lead - Denmark - March 2023
My objective is fully met, namely to understand the basics, being able to calculate, understand and practice calculations (ICER, decision tree, etc). This allows me to become a better sparring partner internally and externally on HE - related topics and discussions.
Boehringer Ingelheim
Joey Dirker, Head of Go-To-Market Transformation Office - Germany - March 2023
Well-recommended courses. You can't find any better courses throughout the world.
MSD
Khaled Arman, Oncology Market Access Manager Jordan & Iran - Jordan - March 2023
Brilliant course design and content. Very relevant, I finished the course feeling like a HE specialist.
UCB
Sam Aldamee, Market Access Lead - United Kingdom - March 2023
A very concrete training with practical cases. Suitable for refreshing your knowledge or getting more insights.
Acticor
Adeline Meilhoc, Head of Global Clinical Development - France - March 2023
Great course that completely met my expectations. I really appreciated the discussions with Lieven and the group, the workshops (break-out sessions) were really useful and relevant.
Ferring
Mariia Tykhonova, Global Medical Training Manager, GMA Medical Excellence - France - December 2022
This course is a concise and well-structured introduction into Health Economics. It helped me to put my initial knowledge into context. In the future I will be able to discuss with Market Access and Pricing colleagues in a more targeted and qualified way. Thanks.
CSL Behring
Gunnar Philipp, Senior Director Medical Affairs - Switzerland - December 2022
Very knowledgeable expert and great added value. Would recommend and attend other courses. Also, very friendly and helpful staff.
Idorsia Pharmaceuticals
Inês Carreira Figueiredo, Medical Doctor, Medical Advisor - United Kingdom - December 2022
Excellent course by a highly professional expert.
MSD
Sherif Alam, Regional Marketing Director - United Arab Emirates - December 2022
Everything was very clearly explained in an engaging way.
Ferring
Kathryn Charlwood, Medical Communications Manager - Ireland - December 2022
Well organised, interactive, clear and meeting expectations: I recommend!
CSL Behring
Sandra Le Quellec, Director Medical Affairs Europe Gene Therapy/Hematology - France - December 2022
The programme is very well balanced in terms of topics, theory and examples and organisation of the course. The lecturer is brilliant. Thanks!
Novartis
Mariya Vladova, Innovative Market Access, Value and Data Insights Manager - Bulgaria - June 2022
Very comprehensive, yet practical and quick, introductory course into HEOR. Lieven is a knowledgeable, clear talker, enthusiastic about his field. Mixed audience in level of experience and companies, very nice. Thanks for everything, I enjoyed the training - it was very useful, nice and well organised.
Astellas
Olga Wedemeier, Sr. Medical Director BeNeLux - The Netherlands - June 2022
Lieven Annemans and his expertise made this a great course. I highly valued the examples from real life, the very clear theory and presentation and also the exercises. I really recommend this course.
Daiichi Sankyo
Pinar Özeken, Director Pricing & Value & Access Specialty Business Division Daiichi Sankyo Europe - Germany - June 2022
This training is a must for non-HE who want to develop further in HE.
GlaxoSmithKline
Raymond Kienhuis, Field Market Access Manager - The Netherlands - June 2022
This training is a MUST for any professional new to the pharma sector. The big picture and key principles of Health Economics are presented in a comprehensive manner and are accompanied with many actionable insights.
Janssen
Jonathan Dicker, Manager Global Pricing Analytics - Belgium - December 2021
The course was very insightful. The expert knowledge of Lieven and his great way of disseminating his knowledge made the course very valuable. Although the course was mainly discussing examples from the pharmaceutical industry, the methods and general application of HE were easily understandable and could easily be transitioned to the medical technology industry as well. Anyone can easily follow the course and really gain sufficient knowledge and insight in HE evaluations, market access methodologies that can help companies improve their chances in achieving greater market access, and efficient ways to approach information and data gathering for amplifying the value of new technologies. Highly recommended!
MedTech Europe
Panagiotis Kokkinos, Digital Health Access Officer - Belgium - December 2021
Lieven really inspired me during this 2-day course.
Janssen
Rudy Taels, Business Intelligence Manager Neurosciences Benelux - The Netherlands - December 2021
A very complete, very insightful course that is useful to apply in a company setting. For me the online experience was excellent, no improvements needed. Thanks a lot to Lieven and to CELforPharma!
Roche
Christel Van-Weert, Head of Reputation Management - Belgium - June 2021
A very clear & concise course that was perfectly fitted to my level of understanding. Not too simple, not too advanced, with a nice balance of lectures and exercises. There was some really fun and constructive interaction within the group and it was interesting to hear from other countries' perspectives during group discussions. Many thanks to all involved!
Sanofi
Erland Marstein, Franchise Lead Immunology Norway - Norway - June 2021
This was a great opportunity to brush up on some skills and to interact with a knowledge expert in the field.
Novartis
Albert Hsu, Director, Global Market Access - Switzerland - March 2021
The HE course was absolutely excellent, pitched at the right level and helped me understand (and demystify!) this topic! There is an excellent balance between theory and practices with tangible real-life examples/illustrations. The trainer was excellent, showed huge expertise and was engaging! I strongly recommend this course!
Vertex Pharmaceuticals
Celine Ladure, International Marketing Director - United Kingdom - March 2021
I highly enjoyed the course. In only 2 days you get a great overview of HE and a couple of very pragmatic tools for how to think about issues in the field, as a layman. The theory becomes very tangible and applicable in everyday life.
Pfizer
Claire-Marie Rothlübbers, Sr Manager Market Access - Switzerland - March 2021
I just loved it! Great training, great teacher, perfectly managed by CELforPharma. It was a perfect mix of theory, group exercises, individual exercises, and discussions. These two days will provide you with all the needed tools to understand and challenge health economics models.
AbbVie
Jade Royers, Jade Royers, Market Access Value Proposition Manager - Belgium - March 2021
I have left the course with a lot more understanding of health economic evaluations, and the complexity in coming up with the data to inform payers and pharma companies in making decisions regarding treatment options. I plan to also follow the HTA course to see what the difference is and explore the possibility of specialising in this field.
Novo Nordisk
Monica Mirigo, Quality Assurance Specialist for Middle Africa - Kenya - March 2021
Very rich and intense experience taking this course. Would highly recommend to anyone looking to sharpen their knowledge and Health Economics understanding and its application in Pharma.
Novo Nordisk
Peter Mburu, Medical Advisor - Southern Africa - Kenya - March 2021
14-15 December 2023, Brussels
Full Fee € 3 070
26-27 March 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 09/02/2024)
3-4 October 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 16/08/2024)
4-5 December 2024, Brussels
Early bird € 2 970
(Full fee € 3 370)
(until 18/10/2024)
Important information:
- Our courses typically take place between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris).
- Live online sessions will be hosted in Zoom.
- Face-to-face courses will take place at a four-star business hotel close to the airport.
- You will receive all practical details after your registration.
For any questions related to the above, please do not hesitate to email Lisa Causero or contact her by phone at +32 484 70 91 97.
How to Register
Click the green "Register" button on the course session of your preference.
The registration wizard will guide you through the personal and company data that we need to process your registration.
You have the choice between 2 payment options:
Payment by credit card. You will not be required to pay immediately, but you will receive a secured payment link together with the invoice.
Payment via bank transfer
Click "Register Now". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.
For assistance with your registration, please email Annelies Swaan or contact her by phone at +32 486 98 52 49.
Included in the Registration Fee:
For face-to-face courses:
Participation in a small-class (max 20 participants), expert led face-to-face course with interactive group exercises and plenary discussions. You will have the opportunity to meet the expert and discuss your own projects/issues during the breaks.
Course material will be provided to you in both digital format (by email) and in hard copy (so you can make notes during the course).
Opportunities for networking and informal discussions during coffee/tea breaks and lunch.
A group dinner in a nearby restaurant on the evening of day 1.
Certificate of attendance signed by the expert and CELforPharma.
VAT Information
The prices on our website are excluding VAT. Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT.
We are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Group Discounts
Team discounts can be offered to 3 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
Transfer & Cancellation Policy
Flexible Transfer
If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
Alternatively, the registrant can transfer once on a “space available” basis at no extra cost, until 3 weeks prior to the event, to another course of the same value held within one year of the original course date.
Registration Cancellation
Less than 14 days prior to the course date: registrant liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: registrant liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: registrant liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.
Benefits of CELforPharma’s face-to-face courses:
You have the unique opportunity to interact 1:1 with the expert(s).
Plenty of opportunity for informal 1:1 and group conversations with your international peers to exchange experiences and ideas, to discuss issues and to network.
Face-to-face interactions allow for more depth during Q&As and group work.
You can step away from your daily routine in the office and enjoy a more focused learning experience in a comfortable business hotel environment.
Benefits of CELforPharma’s live online courses:
The formal programme is as impactful as a face-to-face course thanks to the highly interactive format (using breakouts, polls, quizzes …).
No travel & accommodation expenses
You can attend the course from the comfort of your own office or home.
We send you the course materials by post so that you can take notes and fully engage with the course content.
No, if you choose credit card payment, we will send you a secure payment link together with the invoice.
Team discounts can be offered for 3 or more registrations confirmed at the same time. The level of discount will depend on the number of registrations and the availability of seats.
Email Annelies Swaan, Director Business Operations, for more details.
Depending on the format of the course (face-to-face in Brussels or live online or self-study programme) and your location, we are obliged by Belgian law to apply VAT in the following cases:
Face-to-Face public course organised in Belgium
Article 53 of the European Union VAT Directive 2006/112 states that : “The place of supply of services in respect of admission to cultural, artistic, sporting, scientific, educational, entertainment or similar events, such as fairs and exhibitions, and of ancillary services related to the admission, supplied to a taxable person, shall be the place where those events actually take place.”
If the course that you register for takes place in Belgium, we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Online Public courses - live webinar
Webinars where the participants can communicate among themselves or ask questions to the speaker(s) (be it verbally, via a chat function or similar), are considered as ‘online interactive webinars’ by the Belgian VAT administration.
According to Article 53 of the European Union VAT Directive 2006/112, these online interactive webinars take place where the organisation of the seminar takes place, which in this case is Belgium.
So, if you register for one of our live online courses (organised from our offices in Belgium), we are obliged to charge 21% Belgian VAT.
However, you can recover this Belgian VAT through the refund procedure. Note that this procedure differs depending on the country where you are located. It is best to contact your local VAT administration for this.
Self-Study Programme:
A self-study programme is a service provided electronically. It is the period of self-study that is the most important in our self-study Basics of Health Economics and not the kickoff and closing webinars. As a result, this self-study program follows a different VAT application and the place of the service is where the customer is established. Therefore, we follow the VAT rules applicable to the country of your invoicing address.
Our face-to-face courses in Brussels take place in four-star business hotels close to the airport. As part of our strong relationship with these hotels, CELforPharma has secured a discount on the daily room rate for our delegates who book their accommodation via us.
Upon your registration, we will assist you to make your hotel booking. For any assistance in this matter please do not hesitate to email Lisa Causero, Programme Coordinator, or contact her by phone at +32 484 70 91 97.
We do not record our live online public courses as we want to offer a safe environment for all attendees to share their experiences and freely ask questions.
This way, by participating in our courses, you do not only learn from our expert faculty but also from your international peers in the room.
No, we don't sell the course materials as a stand-alone.
Without the expert's explanation, the exercises and the discussions with other course participants, there is very little value in the slides.
Email Inge Cornelis, partner with CELforPharma, to help you choose the course that is best suited.
Yes!
We have helped many managers with setting up an in-house training programme for their team.
Email Inge Cornelis, partner with CELforPharma, to discuss your team training needs.
Do you have any other questions?
Email Annelies Swaan or call +32 486 98 52 49.
People attending this course are typically also interested in:
By clicking the below button, you will save this course to MY COURSES in the upper right corner of the website. This allows you to quickly retrieve it later.
Don’t forget to make a personal account using the Login button in the upper right corner of the website to keep your list of saved courses for your next visit.